This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
The Zacks Analyst Blog Highlights: Etsy, L Brands, Diamondback Energy, Align Technology and Tapestry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Etsy, L Brands, Diamondback Energy, Align Technology and Tapestry
Zacks.com featured highlights include: Align Technology, Etsy, 1st Constitution Bancorp, PotlatchDeltic and Williams-Sonoma
by Zacks Equity Research
Zacks.com featured highlights include: Align Technology, Etsy, 1st Constitution Bancorp, PotlatchDeltic and Williams-Sonoma
5 Top-Ranked Momentum Stocks Driven by Driehaus Strategy
by Nitish Marwah
The Driehaus strategy can be used to choose the best momentum stocks using the "buy high and sell higher" theory.
5 S&P 500 Stocks That Zoomed 200% Plus From Pandemic Lows
by Sweta Killa
After touching a low of 2,191 on Mar 23, 2020, the S&P 500 staged a strong comeback and is on track to hit a new milestone of 4,000.
Top Stock Picks for Week of March 22, 2021
by Panel Of Zacks Experts
A Company in a Hot Space and a Medical Device Company with "A" Rated Momentum.
U.S. GDP and Corporate Profits Likely to Soar in 2021: 5 Picks
by Nalak Das
We have narrowed down our search to the five large-cap S&P 500 stocks that have strong growth potential in 2021. These are: PXD, LB, NUE, ALGN and EOG.
Bear of the Day: Gold Fields (GFI)
by Kevin Cook
Miners continue to underperform the barbarous relic over the long term and you should know why
Veeva (VEEV) Application Completes Consent for First Patient (Revised)
by Zacks Equity Research
With this latest development, Veeva (VEEV) is likely to strengthen its portfolio of cloud-based offerings.
3 Top-Ranked Tech Stocks to Buy Now Despite Volatility
by Benjamin Rains
Here are three top-ranked Zacks stocks from the broader technology world that investors might want to buy amid inflation worries and market volatility...
Veeva (VEEV) Application Completes Consent for First Patient
by Zacks Equity Research
With this latest development, Veeva (VEEV) is likely to strengthen its portfolio of cloud-based offerings.
Medtronic (MDT) Gets FDA Nod for Revised Neuromodulation Labeling
by Zacks Equity Research
This latest development is expected to contribute to Medtronic's (MDT) pain therapy business in the coming months.
Align Technology (ALGN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $540.01 in the latest trading session, marking a -0.47% move from the prior day.
Why You Should Add Surmodics (SRDX) to Your Portfolio Now
by Zacks Equity Research
Investor optimism is high on Surmodics (SRDX) stock, courtesy of its solid prospects.
Stock Market News for Mar 16, 2021
by Zacks Equity Research
Benchmarks closed modestly higher on Monday as investors continued to show optimism about economic recovery
Luminex (LMNX) Files EUA Application for New Respiratory Assay
by Zacks Equity Research
Luminex (LMNX) develops the combined assay to rapidly deliver clear solutions about respiratory infections from a single test.
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
by Zacks Equity Research
Investor confidence is high on Allscripts (MDRX) stock, courtesy of solid prospects.
Here's Why You Should Add Hill-Rom (HRC) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about robust demand for Hill-Rom's (HRC) product as well as its solid first-quarter fiscal 2021 results.
Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona
by Zacks Equity Research
Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona
Top Analyst Reports for UnitedHealth, Pfizer & IBM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Pfizer (PFE), and International Business Machines (IBM).
3 Stocks to Capitalize on Promising Dental Supplies Industry
by Trina Mukherjee
Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.
Intersect ENT (XENT) Q4 Loss Wider Than Expected, Revenues Top
by Zacks Equity Research
Intersect ENT's (XENT) sequentially rebound is strong on continued recovery in PROPEL, growth in SINUVA and initial sales of the company???s newly acquired Fiagon products.
Here's Why You Should Retain AMN Healthcare (AMN) Stock Now
by Zacks Equity Research
Investor optimism is high on AMN Healthcare (AMN) stock, courtesy of its solid prospects.
5 Beaten-Down Stocks of Nasdaq ETF With Upside Potential
by Sweta Killa
We highlighted five stocks from the ETF that were hit badly in the tech rout but might reverse the trend, given their solid Zacks Rank #1 (Strong Buy) or 2 (Buy) and positive earnings estimate revisions in a month.
Why Align Technology (ALGN) Stock Might be a Great Pick
by Zacks Equity Research
Align Technology (ALGN) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.